Hualan Biological Engineering Inc.

SZSE:002007 Stock Report

Market Cap: CN¥31.8b

Hualan Biological Engineering Past Earnings Performance

Past criteria checks 4/6

Hualan Biological Engineering's earnings have been declining at an average annual rate of -1.6%, while the Biotechs industry saw earnings growing at 7.6% annually. Revenues have been growing at an average rate of 5.2% per year. Hualan Biological Engineering's return on equity is 10.9%, and it has net margins of 27.2%.

Key information

-1.6%

Earnings growth rate

-1.7%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate5.2%
Return on equity10.9%
Net Margin27.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Hualan Biological Engineering (SZSE:002007) Seems To Use Debt Quite Sensibly

Nov 18
Hualan Biological Engineering (SZSE:002007) Seems To Use Debt Quite Sensibly

Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 36% Below Their Intrinsic Value Estimate

Oct 07
Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 36% Below Their Intrinsic Value Estimate

Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Aug 22
Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jun 26
Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate

Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30

Jun 09
Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30

These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely

Jun 07
These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely

Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

May 21
Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Feb 27
Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Revenue & Expenses Breakdown

How Hualan Biological Engineering makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002007 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,9201,3381,210275
30 Jun 245,4091,3951,473280
31 Mar 245,2491,3921,455276
31 Dec 235,3421,4821,479281
30 Sep 234,8281,2431,299311
30 Jun 233,7531,020734310
31 Mar 234,7571,1941,297329
01 Jan 234,5171,0761,238315
30 Sep 224,6771,1391,258284
30 Jun 225,4971,4251,604280
31 Mar 224,4531,2771,008263
01 Jan 224,4361,2991,022254
30 Sep 215,3111,7091,482259
30 Jun 214,9251,5591,358257
31 Mar 214,9691,6211,344235
31 Dec 205,0231,6131,371213
30 Sep 204,1341,2841,027184
30 Jun 203,6841,288739155
31 Mar 203,6821,271705143
31 Dec 193,7001,283744144
30 Sep 193,8191,344813171
30 Jun 193,4181,194728163
31 Mar 193,3511,192758158
31 Dec 183,2171,140728146
30 Sep 182,738961529116
30 Jun 182,556843441181
31 Mar 182,392773456151
31 Dec 172,368821462129
30 Sep 172,19579240694
30 Jun 172,0918014250
31 Mar 172,0618434010
31 Dec 161,9357803590
30 Sep 161,7677372610
30 Jun 161,6716902670
31 Mar 161,5856322430
31 Dec 151,4725892340
30 Sep 151,3865752500
30 Jun 151,3725632470
31 Mar 151,2635142340
31 Dec 141,2435382270
30 Sep 141,2375472090
30 Jun 141,1415301840
31 Mar 141,1045191840
31 Dec 131,1184751710

Quality Earnings: 002007 has high quality earnings.

Growing Profit Margin: 002007's current net profit margins (27.2%) are higher than last year (25.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002007's earnings have declined by 1.6% per year over the past 5 years.

Accelerating Growth: 002007's earnings growth over the past year (7.6%) exceeds its 5-year average (-1.6% per year).

Earnings vs Industry: 002007 earnings growth over the past year (7.6%) exceeded the Biotechs industry 1.3%.


Return on Equity

High ROE: 002007's Return on Equity (10.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:11
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hualan Biological Engineering Inc. is covered by 42 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ethan CuiBofA Global Research
Min LuoCentral China Securities Co., Ltd.
Shuchang LiuChangjiang Securities Co. LTD.